Recently Viewed
Clear All
IPO Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Bidding Date
23-Sep-2025 to
25-Sep-2025
Issue Size
₹13.02 Cr
Price Band
₹65 to ₹70
Allotment date
26-Sep-2025
Listing date
30-Sep-2025
Lot size
2000
No. of shares
18,60,000
Fresh issue/OFS
₹13.02 Cr /--
Aptus Pharma Ltd., established in 2010, has evolved from its initial focus on pharmaceutical marketing to become a diversified player in the manufacturing, marketing, and distribution of finished pharmaceutical formulations, serving acute and chronic therapy segments. Over the years, the company expanded its portfolio to more than 70 products across multiple divisions, addressing the needs of healthcare professionals through state-of-the-art, WHO/cGMP-compliant manufacturing and rigorous quality assurance practices. Aptus Pharma’s core strength lies in its deep relationships with over 6,500 doctors and 125 distributors, a strong field force, and dedicated divisions that cater to a broad spectrum of healthcare requirements both in India and emerging global markets. The company's approach emphasizes quality, compliance, reliability, and close engagement with healthcare stakeholders, enabling it to respond effectively to industry demands and maintain high standards in product delivery and client support.
Category
Status
QIBs
1.2x
NIIs
21.5x
Retail
31.4x
Others
--
Total
20.8x
| Name | Price Band (Rs) | Bidding Date |
|---|---|---|
| Emiac Technologies | 93 - 98 | 27-Mar-2026 to 08-Apr-2026 |
| Safety Controls & Devices | 75 - 80 | 06-Apr-2026 to 08-Apr-2026 |
| Vivid Electromech | 528 - 555 | 25-Mar-2026 to 30-Mar-2026 |
| Amir Chand Jagdish Kumar (Exports) | 201 - 212 | 24-Mar-2026 to 27-Mar-2026 |
The issue size of Aptus Pharma is ₹13.02 Cr.
Aptus Pharma falls into Pharmaceuticals industry.
The Aptus Pharma IPO will be listed on NSE.
The open and close dates for the Aptus Pharma are 23-Sep-2025 & 25-Sep-2025.
The price band for the Aptus Pharma ipo is ₹65 to ₹70
The listing date of Aptus Pharma IPO is 30-Sep-2025.
The purpose of this IPO is to raise fresh capital.
Aptus Pharma total subscription ratio is 20.8X.
Key financial of the Aptus Pharma are:
| Aptus Pharma | FY-25 | FY-24 | FY-23 |
|---|---|---|---|
| Revenue (₹ Cr) | 24.56 | 17.86 | 13.9 |
| EBIT (₹ Cr) | 4.58 | 1.33 | 0.44 |
| Proft after Tax (₹ Cr) | 3.1 | 0.8 | 0.19 |
| Debt (₹ Cr) | 10.36 | 5.31 | 2.21 |
| Net Worth (₹ Cr) | 6.97 | 1.77 | 0.97 |
| RoE (%) | 44.5 | 45.18 | 20.06 |
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
